- Report
- July 2026
- 590 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- July 2026
- 462 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- July 2026
- 473 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- July 2026
- 373 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- July 2026
- 250 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- July 2026
- 179 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- July 2026
- 193 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- July 2026
- 302 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- July 2026
- 247 Pages
Global
From €5309EUR$5,850USD£4,524GBP
- Report
- May 2026
- 180 Pages
Global
From €4084EUR$4,500USD£3,480GBP
- Report
- December 2025
- 200 Pages
Global
From €7215EUR$7,950USD£6,148GBP
- Clinical Trials
- April 2026
- 60 Pages
Global
From €1361EUR$1,500USD£1,160GBP
- Report
- May 2026
- 150 Pages
Global
From €2449EUR$2,699USD£2,087GBP
- Report
- July 2025
- 350 Pages
Global
From €4491EUR$4,949USD£3,827GBP
- Report
- July 2026
- 160 Pages
Global
From €3766EUR$4,150USD£3,209GBP
- Report
- January 2026
- 141 Pages
Global
From €3585EUR$3,950USD£3,055GBP
- Report
- February 2026
- 299 Pages
Global
From €5037EUR$5,550USD£4,292GBP
- Report
- November 2025
- 193 Pages
Global
From €4492EUR$4,950USD£3,828GBP
- Report
- November 2025
- 101 Pages
Global
From €3131EUR$3,450USD£2,668GBP
- Report
- June 2026
- 200 Pages
Asia Pacific
From €2713EUR$2,990USD£2,312GBP

Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs.
The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more